Mizuho Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $28

Futu NewsDec 24 03:31 · Ratings

U.S. Healthcare Spending Climbs 7.5% in 2023

Seeking AlphaDec 20 04:43

Investors in Surgery Partners (NASDAQ:SGRY) Have Unfortunately Lost 53% Over the Last Three Years

Simply Wall StDec 17 19:50

Worst Performing Stocks for Tax Loss Selling – Wolfe

Seeking AlphaDec 17 03:59

BofA Securities Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $30

Futu NewsDec 16 20:31 · Ratings

JPMorgan Adjusts Surgery Partners Price Target to $28 From $38, Maintains Neutral Rating

MT NewswiresDec 3 20:35 · Ratings